Premium Phosphosite-Specific 7TM Antibodies
Novel Tools for Your GPCR Research
Select Your Country of Delivery below

PAR4 (non-phospho), Proteinase-Activated Receptor 4 Antibody

NEW
Validation of the Proteinase-Activated Receptor 4 in transfected HEK293 cells
$ 375.00 *

Prices plus VAT plus shipping costs

Ready to ship today,
Delivery time appr. 5-8 days

  • 7TM0350N
  • 100 µl
  • Rabbit
The non-phospho-PAR4 receptor antibody is directed against the distal end of the... more

The non-phospho-PAR4 receptor antibody is directed against the distal end of the carboxyl-terminal tail of human Proteinase-Activated Receptor 4. It can be used to detect total PAR4 receptors in Western blots independent of phosphorylation. The PAR4 antibody can also be used to isolate and enrich PAR4 receptors from cell and tissue lysates.

  Alternative Names Coagulation Factor II Receptor-like 3, Protease-Activated... more

 

Alternative Names Coagulation Factor II Receptor-like 3, Protease-Activated Receptor 4, Thrombin receptor-like 3
IUPHAR Target ID  350
UniProt ID  Q96RI0
Western Blot (WB)  1:1000
Species Reactivity   Human
Host / Isotype Rabbit / IgG
Class Polyclonal
Immunogen A synthetic peptide presents distal part of carboxyl-terminal tail of human PAR4.
Form  Liquid
Purification Antigen affinity chromatography
Storage buffer Dulbecco's PBS, pH 7.4, with 150 mM NaCl, 0.02% sodium azide
Storage conditions short-term 4°C, long-term -20°C
Figure 1. Validation of the Proteinase-Activated Receptor 4 in transfected HEK293 cells.... more

Figure 1. Validation of the Proteinase-Activated Receptor 4 in transfected HEK293 cells. Native HEK293 cells (MOCK) or HEK293 cells stably expressing the Proteinase-Activated Receptor 4 (PAR4) were lysed and immunoblotted with the anti-PAR4 antibody (7TM0350N) at a dilution of 1:1000. 

 

Read, write and discuss reviews... more
Customer evaluation for "PAR4 (non-phospho), Proteinase-Activated Receptor 4 Antibody"
Write an evaluation
Evaluations will be activated after verification.

The fields marked with * are required.

Recently viewed